PPARGC1A and fatty liver disease: PGC-1α, a transcriptional coactivator, is highly expressed in tissues with high energy demands, exhibiting a significant correlation with the pathogenesis of metabolic syndromes such as obesity, T2DM, cardiovascular disease, and hepatic steatosis [67].